Opioids increase hip fracture risk: a meta-analysis
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The relationship between hip fracture risk and opioid use remains controversial. Thus, we performed a meta-analysis to assess the risk of hip fracture among opioid users. PubMed and EMBASE were searched for studies published from the inception of the databases until June 2015. The information was extracted independently by two teams of authors. When the heterogeneity was significant, the random-effects model was used to calculate the overall pooled risk estimates. Ten studies with 697,011 patients were included in the final meta-analysis. The overall combined relative risk for the use of opioids and hip fracture was 1.54 [95 % confidence interval (CI) 1.34-1.77]. Subgroup analyses revealed sources of heterogeneity, and sensitivity analysis indicated stable results, and no publication bias was observed. This meta-analysis demonstrates that opioids significantly increase the risk of hip fracture.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Use of exogenous opioids has been associated with an increased risk of fractures in several meta-analyses (245-248).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [245]
In the citing paper
“reported an increased risk for hip fractures (245)”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [245]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“1 and the I(2) value was >50 %, the data were considered heterogeneous, and a random-effects model (Der-Simonian and Laird method) [19] was utilized because it represented a more conservative approach to the calculation of a weighted estimate effect using an RR.”
MethodOperating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Hip fractures in the elderly: A world-wide projection
Cooper, C., Campion, G., & Melton, L. J. (1992) · Osteoporosis International · doi:10.1007/bf01623184 · Cited by 3,213
ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
WOOLF, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,723
Opioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
Major increases in opioid analgesic abuse in the United States: Concerns and strategies
Compton, W. M., & Volkow, N. D. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.009 · Cited by 830
Central Nervous System–Active Medications and Risk for Falls in Older Women
Ensrud, K. E., Blackwell, T. L., Mangione, C. M., Bowman, P. J., Whooley, M. A., Bauer, D. C., Schwartz, A. V., Hanlon, J. T., Nevitt, M. C., & For The Study of Osteoporotic Fractures Research Group (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50453.x · Cited by 620
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Opioid Therapy and Immunosuppression: A Review
Vallejo, R., de Leon-Casasola, O., & Benyamin, R. (2004) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000132250.95650.85 · Cited by 386
Central Nervous System Active Medications and Risk for Fractures in Older Women
Ensrud, K. E. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.949 · Cited by 277
Fracture risk associated with the use of morphine and opiates
VESTERGAARD, P., REJNMARK, L., & MOSEKILDE, L. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01667.x · Cited by 244
Psychotropic Medications and the Risk of Fracture: A Meta-Analysis
Takkouche, B., Montes-Mart??nez, A., Gill, S. S., & Etminan, M. (2007) · Drug Safety · doi:10.2165/00002018-200730020-00006 · Cited by 204 · cited 3×
“A previous meta-analysis [8] suggested that opioids are associated with a 36 % increase in the risk of hip fracture.”
BackgroundMethodInfluentialGuo, Z., Wills, P., Viitanen, M., Fastbom, J., & Winblad, B. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009714 · Cited by 167
Opioid Analgesics and the Risk of Hip Fracture in the Elderly: Codeine and Propoxyphene
Shorr, R. I., Griffin, M. R., Daugherty, J. R., & Ray, W. A. (1992) · Journal of Gerontology · doi:10.1093/geronj/47.4.m111 · Cited by 156
Card, T., West, J., Hubbard, R., & Logan, R. F. A. (2004) · Gut · doi:10.1136/gut.2003.026799 · Cited by 146
Li, L., Setoguchi, S., Cabral, H., & Jick, S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt013 · Cited by 100
Cigarette smoking and risk of hip fracture in women: A meta-analysis of prospective cohort studies
Shen, G., Li, Y., Zhao, G., Zhou, H. B., Xie, Z. G., Xu, W., Chen, H. N., Dong, Q. R., & Xu, Y. J. (2015) · Injury · doi:10.1016/j.injury.2015.04.008 · Cited by 84
Thorell, K., Ranstad, K., Midlöv, P., Borgquist, L., & Halling, A. (2014) · BMC Geriatrics · doi:10.1186/1471-2318-14-131 · Cited by 82
Parker, M. J., & Pryor, G. A. (1993) · Medical Entomology and Zoology · Cited by 81
The relationship between vitamin A and risk of fracture: Meta-analysis of prospective studies
Wu, A.-M., Huang, C.-Q., Lin, Z.-K., Tian, N.-F., Ni, W.-F., Wang, X.-Y., Xu, H.-Z., & Chi, Y.-L. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2237 · Cited by 72
Opioids contribute to fracture risk: a meta-analysis of 8 cohort studies
Teng, Z., Zhu, Y., Wu, F., Zhu, Y., Zhang, X., Zhang, C., Wang, S., & Zhang, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128232 · Cited by 53 · cited 4×
“[6], which demonstrated a significantly increased risk of hip fracture secondary to opioid use.”
BackgroundInfluentialOpioids in hip fracture patients: An analysis of mortality and post hospital opioid use
Lindestrand, A. G., Christiansen, M. L. S., Jantzen, C., van der Mark, S., & Andersen, S. E. (2015) · Injury · doi:10.1016/j.injury.2015.04.016 · Cited by 49
Propoxyphene use and risk for hip fractures in older adults
Kamal‐Bahl, S. J., Stuart, B., & Beers, M. H. (2006) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2006.09.005 · Cited by 43
Gumieiro, D. N., Rafacho, B. P. M., Pereira, B. L. B., Cavallari, K. A., Tanni, S. É., Azevedo, P. S., Polegato, B. F., Zornoff, L. A. M., Dinhane, D. I., Dinhane, K. G. I., et al. (2014) · Nutrition · doi:10.1016/j.nut.2014.12.022 · Cited by 42
Drugs and femoral neck fracture: a case‐control study
JENSEN, J., NIELSEN, L. H., LYHNE, N., HALLAS, J., BRØSEN, K., & GRAM, L. F. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00302.x · Cited by 33
Nicotine alters the expression of molecular markers of endocrine disruption in zebrafish
Kanungo, J., Cuevas, E., Guo, X., López, A. G., Ramirez-Lee, M. A., Trickler, W. J., Paule, M. G., & Ali, S. F. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.08.027 · Cited by 33
Psychoactive medicine use and the risk of hip fracture in older people: a case-crossover study
Leach, M. J., Pratt, N. L., & Roughead, E. E. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3785 · Cited by 29
HARDINGE, K. (1994) · BMJ · doi:10.1136/bmj.308.6924.349 · Cited by 14
Opioids in the management of persistent, non-cancer pain
Stewart, G., & Owen, M. (2011) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2010.10.012 · Cited by 3
Opioids in the management of persistent non-cancer pain
Stewart, G., & Owen, M. (2013) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2013.09.002 · Cited by 3
Cited by
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
Yoshikawa, A., Ramirez, G., Smith, M. L., Foster, M., Nabil, A. K., Jani, S. N., & Ory, M. G. (2020) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glaa038 · Cited by 122
Medications associated with fracture risk in patients with rheumatoid arthritis
Özen, G., Pedro, S., Wolfe, F., & Michaud, K. D. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215328 · Cited by 110
Bell, K. L., Shohat, N., Goswami, K., Tan, T. L., Kalbian, I. L., & Parvizi, J. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.05.027 · Cited by 98
The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice
Marcianò, G., Vocca, C., Evangelista, M., Palleria, C., Muraca, L., Galati, C., Monea, F., Sportiello, L., Sarro, G. D., Capuano, A., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041165 · Cited by 83
Metadata
- Authors
- Ping, F., Wang, Y., Wang, J., Chen, J., Zhang, W., Zhi, H., & Liu, Y.
- Affiliations
- Hebei University of Engineering (CN)
- Corresponding author
- Zhi, Hua
- Liu, Yugang
- Venue
- Journal of Bone and Mineral Metabolism
- Published
- 2016-03-29
- Volume
- 35
- Issue
- 3
- Pages
- 289-297
- ISSN
- 0914-8779 (ISSN-L)
- 1435-5604
- OpenAlex
- W2316852869
- Cited by
- 36
- References
- 32
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 7 · 2019: 4 · 2018: 5 · 2017: 3
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Bone and Mineral Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- opioids, hip fracture, fracture risk, osteoporosis, bone fragility
- MeSH terms
- Aged, Analgesics, Opioid, Hip Fractures, Humans, Middle Aged, Opioid-Related Disorders, Risk Factors, Cohort Studies, Publication Bias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.